Memphasys Ltd (MEM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.306x

Based on the latest financial reports, Memphasys Ltd (MEM) has a cash flow conversion efficiency ratio of -0.306x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.23 Million ≈ $-871.57K USD) by net assets (AU$4.02 Million ≈ $2.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see MEM company net worth for the company's overall valuation and market capitalisation.

Memphasys Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Memphasys Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Memphasys Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Memphasys Ltd ranked by their cash flow conversion efficiency. Explore Memphasys Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
NEVADA LITHIUM RESOURCES
F:87K
-0.009x
Ihlas Ev Aletleri Imalat Sanayi ve Ticaret AS
IS:IHEVA
0.009x
Arita Prima Indonesia Tbk
JK:APII
0.022x
Intrasense
PA:ALINS
0.452x
MODERN COMMERCE SA ZY-10
F:8F4
-0.261x
Integritas Viager SA
PA:MLVIE
N/A
Swissnet AG
F:81D
N/A
FN Factory Outlet Public Company Limited
BK:FN
-0.024x

Annual Cash Flow Conversion Efficiency for Memphasys Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Memphasys Ltd from 2008 to 2025. View latest Memphasys Ltd stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$5.37 Million
≈ $3.80 Million
AU$-2.41 Million
≈ $-1.71 Million
-0.449x +5.01%
2024-06-30 AU$6.84 Million
≈ $4.84 Million
AU$-3.23 Million
≈ $-2.29 Million
-0.473x -148.09%
2023-06-30 AU$7.38 Million
≈ $5.23 Million
AU$-1.41 Million
≈ $-995.31K
-0.190x -567.12%
2022-06-30 AU$7.65 Million
≈ $5.41 Million
AU$311.82K
≈ $220.63K
0.041x +685.09%
2021-06-30 AU$8.61 Million
≈ $6.09 Million
AU$44.71K
≈ $31.63K
0.005x -57.84%
2020-06-30 AU$9.76 Million
≈ $6.90 Million
AU$120.19K
≈ $85.05K
0.012x +110.57%
2019-06-30 AU$6.07 Million
≈ $4.30 Million
AU$-707.47K
≈ $-500.58K
-0.117x +47.11%
2018-06-30 AU$3.35 Million
≈ $2.37 Million
AU$-738.42K
≈ $-522.48K
-0.220x -107.21%
2017-06-30 AU$-402.24K
≈ $-284.61K
AU$-1.23 Million
≈ $-869.31K
3.054x +455.22%
2016-06-30 AU$1.48 Million
≈ $1.05 Million
AU$-1.27 Million
≈ $-899.02K
-0.860x +73.50%
2015-06-30 AU$746.59K
≈ $528.26K
AU$-2.42 Million
≈ $-1.71 Million
-3.244x -442.08%
2014-06-30 AU$-992.85K
≈ $-702.50K
AU$-941.64K
≈ $-666.27K
0.948x +771.03%
2013-06-30 AU$6.99 Million
≈ $4.95 Million
AU$-987.97K
≈ $-699.05K
-0.141x +1.56%
2012-06-30 AU$4.56 Million
≈ $3.23 Million
AU$-655.09K
≈ $-463.52K
-0.144x +40.80%
2011-06-30 AU$7.00 Million
≈ $4.95 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.243x -18.49%
2010-06-30 AU$12.84 Million
≈ $9.09 Million
AU$-2.63 Million
≈ $-1.86 Million
-0.205x +79.64%
2009-06-30 AU$-398.47K
≈ $-281.94K
AU$400.62K
≈ $283.46K
-1.005x +72.30%
2008-06-30 AU$1.10 Million
≈ $779.28K
AU$-4.00 Million
≈ $-2.83 Million
-3.630x --

About Memphasys Ltd

AU:MEM Australia Medical Devices
Market Cap
$13.11 Million
AU$18.52 Million AUD
Market Cap Rank
#26465 Global
#1208 in Australia
Share Price
AU$0.01
Change (1 day)
+20.00%
52-Week Range
AU$0.00 - AU$0.01
All Time High
AU$0.37
About

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port… Read more